International Stem Cell Corporation (ISCO)
OTCMKTS: ISCO · Delayed Price · USD
0.103
+0.042 (68.00%)
Mar 27, 2024, 10:48 AM EDT - Market closed
International Stem Cell Market Cap
International Stem Cell has a market cap or net worth of $489.07 thousand as of March 28, 2024. Its market cap has decreased by -71.07% in one year.
Market Cap
489.07K
Enterprise Value
3.26M
1-Year Change
-71.07%
Ranking
n/a
Category
Stock Price
$0.10
Market Cap Chart
Since March 28, 2019, International Stem Cell's market cap has decreased from $9.99M to $489.07K, a decrease of -95.10%. That is a compound annual growth rate of -45.30%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 26, 2024 | 489.07K | -38.90% |
Mar 25, 2024 | 800.44K | 91.94% |
Mar 22, 2024 | 417.03K | -39.10% |
Mar 20, 2024 | 684.78K | 22.21% |
Mar 19, 2024 | 560.31K | -17.65% |
Mar 15, 2024 | 680.37K | -22.73% |
Mar 13, 2024 | 880.48K | 10.00% |
Mar 11, 2024 | 800.44K | - |
Mar 8, 2024 | 800.44K | - |
Mar 7, 2024 | 800.44K | - |
Mar 5, 2024 | 800.44K | - |
Mar 4, 2024 | 800.44K | -4.76% |
Mar 1, 2024 | 840.46K | 35.48% |
Feb 28, 2024 | 620.34K | -3.13% |
Feb 27, 2024 | 640.35K | -1.23% |
Feb 26, 2024 | 648.36K | 0.87% |
Feb 23, 2024 | 642.75K | -19.70% |
Feb 22, 2024 | 800.44K | -16.67% |
Feb 21, 2024 | 960.53K | 20.00% |
Feb 20, 2024 | 800.44K | 2.35% |
Feb 16, 2024 | 782.03K | 22.13% |
Feb 15, 2024 | 640.35K | -4.53% |
Feb 14, 2024 | 670.77K | 19.71% |
Feb 13, 2024 | 560.31K | -1.48% |
Feb 12, 2024 | 568.71K | -21.06% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 735.08B |
Novo Nordisk | 580.33B |
UnitedHealth Group | 450.93B |
Johnson & Johnson | 374.05B |
Merck & Co. | 317.37B |
AbbVie | 317.35B |
Thermo Fisher | 218.71B |
AstraZeneca | 207.09B |